Across the pharmaceutical industry, supply chain leaders are facing a familiar set of challenges: fragmented data systems, limited visibility, and an overreliance on manual processes. As logistics operations scale to meet global demand, many organisations are discovering that their current infrastructure struggles to keep up - especially when it comes to cold chain compliance, temperature data management, and KPI reporting. Much of the strain comes from the way data is collected and handled. It’s still typical for teams to receive temperature logger outputs in PDF or Excel format, store them in places like SharePoint, and manually clean and reconcile information before it can be analysed. This fragmentation not only slows down operations, it also limits the ability to identify risk patterns or take timely corrective action. Business intelligence (BI) tools are often in place, but they tend to offer retrospective visibility. Most dashboards show what went wrong after the fact - not what

Balancing cost-efficiency, quality, and compliance in external manufacturing is more challenging than ever for pharmaceutical supply chain professionals. As the landscape grows increasingly complex, new obstacles are emerging that can significantly impact your operational performance and bottom line. Are you grappling with these critical challenges? Limited supply chain visibility Rising costs and budget unpredictability Mitigating regulatory compliance risks Join our exclusive webinar on Tuesday, 17th June 2025, at 3:00 pm (BST) to gain practical strategies for overcoming these hurdles. We’ll show you how digitising your procurement process can help you: - Strengthen stock inventory management - Reduce operational costs - Enhance compliance and transparency This interactive session will also explore how automation can synchronise your external manufacturers with your internal supply chain teams, streamlining workflows and unlocking significant cost savings by reducing manual tasks and

April 16, 2025 Faced with regulatory requirements, geopolitical developments, sustainability pressures and operational complexity, supply chain leaders can no longer afford to operate reactively. To maintain resilience and competitiveness, they must adopt a proactive approach, leveraging data-driven insights and fostering collaboration across the value chain to effectively manage potential disruptions. This was the driving theme behind the CxO Fireside Chat at the LogiPharma 2025 conference. Senior executives from across the pharmaceutical and logistics sectors came together in France in early April to explore what it means to build a truly proactive supply chain, and what it will take to get there. The next five years will be a turning point for pharma supply chains, as the industry will see a dramatic transformation in how manufacturers operate. To learn more about this, we spoke to Adam Ruiz, Growth Business Development Representative at Veratrak, who attended the conference in Fran

Optimising external manufacturing cost-effectiveness while maintaining high-quality standards and regulatory compliance is increasingly complex and challenging. Supply chain professionals face a myriad of challenges that can significantly impact their operations and bottom line. Rising external manufacturing costs are squeezing profit margins, while a lack of supply chain visibility and poor supplier performance hinder efficiency and responsiveness. Meanwhile, ensuring business continuity in the face of disruptions has become a critical imperative. While supply chain disruptions have eased since the COVID-19 pandemic, companies are still grappling with higher costs for materials compared to pre-pandemic levels. Inflation has emerged as a major concern for pharmaceutical companies, with 40% of industry professionals identifying it as the top challenge in 2023¹. This has led to increased costs for raw materials, energy, and labour, putting pressure on profit margins. Regulatory complianc

Read our case study to discover how a British pharmaceutical company reduced their operational integration costs and streamlined activities with their logistics services providers by leveraging Veratrak’s Hub platform. Customer Profile Top 10 Global Pharma (UK based) £100 million per year spent on outsourcing consultants to manage partners’ interfaces Background A leading British Pharma company faced substantial costs and operational challenges related to managing global interfaces with third-party logistics providers (3PLs). With expenditures exceeding £100 million annually on outsourced consultants for interface maintenance and support, they sought a more efficient and proactive solution to mitigate risks and reduce dependency on external support. Veratrak’s engagement identified a 58% opportunity to reduce effort once warehouses are connected to the Hub platform, and a 40% cost reduction opportunity. The Challenge Despite the significant investment in outsourcing, the Pharma company

Relying on a password alone is not enough to keep online accounts safe; many sectors, particularly in life sciences and finance, require stringent security measures. By implementing multi-factor authentication (MFA), companies not only safeguard against data breaches but also ensure they meet regulatory standards, preventing legal and financial repercussions. In this article, we talk to Heléna Kattenhorn, Product Manager at Veratrak, to learn more about the advantages of using MFA as a fundamental component in meeting security requirements and protecting sensitive data. Can you tell us more about MFA, and why it matters? Implementing Multi-factor Authentication (MFA) provides a powerful multi-layered defense. MFA is a security mechanism that requires users to provide two or more verification factors to gain access to a resource such as an application, online account, or VPN. Unlike traditional password-based systems, MFA adds extra layers of security, significantly reducing the risk of